Targeting MYCN and ALK in resistant and relapsing neuroblastoma
Author(s) -
Elizabeth R. Tucker,
Evon Poon,
Louis Chesler
Publication year - 2019
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2019.009
Subject(s) - neuroblastoma , anaplastic lymphoma kinase , cancer research , crizotinib , medicine , targeted therapy , oncogene , alk inhibitor , disease , oncology , biology , cancer , lung cancer , genetics , cell cycle , cell culture , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom